来自MSN2 个月
Clinical trial suggests new drug candidate for spinocerebellar ataxia may offer certain ...More information: Tomohiko Ishihara et al, L-arginine in patients with spinocerebellar ataxia type 6: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial, eClinicalMedicine ...
Considering taking supplements to treat spinocerebellar ataxia sca? Below is a list of common natural remedies used to treat or reduce the symptoms of spinocerebellar ataxia sca. Follow the links ...
Find effective medications for 'Spinocerebellar Ataxia treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed ...
About SCA3 Spinocerebellar ataxia type 3 (SCA3) is a rare neuromuscular disease with a prevalence of one to five in 100,000 people. It is the most common form of spinocerebellar ataxia.
The remaining candidates, ARO-MMP7 and ARO-ATXN2, are being developed to treat idiopathic pulmonary fibrosis (IPF) and spinocerebellar ataxia 2 (SCA2 ... ataxia type 1, spinocerebellar ataxia ...
Spinocerebellar Ataxia (SCA) is a rare ... with troriluzole showed a 50-70% slower rate of decline, representing 1.5-2.2 years delay in disease progression, over the 3-year study period (Figures ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果